关注
Hideho Okada
Hideho Okada
Professor of Neurological Surgery
在 ucsf.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
DM O’Rourke, MLP Nasrallah, A Desai, JJ Melenhorst, K Mansfield, ...
Science translational medicine 9 (399), eaaa0984, 2017
15422017
Actively personalized vaccination trial for newly diagnosed glioblastoma
N Hilf, S Kuttruff-Coqui, K Frenzel, V Bukur, S Stevanović, ...
Nature 565 (7738), 240-245, 2019
7612019
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
H Okada, M Weller, R Huang, G Finocchiaro, MR Gilbert, W Wick, ...
The Lancet Oncology 16 (15), e534-e542, 2015
6952015
Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic …
H Okada, P Kalinski, R Ueda, A Hoji, G Kohanbash, TE Donegan, ...
Journal of clinical oncology 29 (3), 330-336, 2011
6842011
Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment
S Müller, G Kohanbash, SJ Liu, B Alvarado, D Carrera, A Bhaduri, ...
Genome biology 18, 1-14, 2017
5662017
Classification of current anticancer immunotherapies
L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ...
Oncotarget 5 (24), 12472, 2014
5582014
Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma
LA Johnson, J Scholler, T Ohkuri, A Kosaka, PR Patel, SE McGettigan, ...
Science translational medicine 7 (275), 275ra22-275ra22, 2015
4962015
COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells
M Fujita, G Kohanbash, W Fellows-Mayle, RL Hamilton, Y Komohara, ...
Cancer research 71 (7), 2664-2674, 2011
4152011
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas
G Kohanbash, DA Carrera, S Shrivastav, BJ Ahn, N Jahan, T Mazor, ...
The Journal of clinical investigation 127 (4), 1425-1437, 2017
3742017
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma
JH Choe, PB Watchmaker, MS Simic, RD Gilbert, AW Li, NA Krasnow, ...
Science translational medicine 13 (591), eabe7378, 2021
2852021
STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment
T Ohkuri, A Ghosh, A Kosaka, J Zhu, M Ikeura, M David, SC Watkins, ...
Cancer immunology research 2 (12), 1199-1208, 2014
2292014
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models
X Zhu, F Nishimura, K Sasaki, M Fujita, JE Dusak, J Eguchi, ...
Journal of translational medicine 5, 1-15, 2007
2252007
Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and …
IF Pollack, RI Jakacki, LH Butterfield, RL Hamilton, A Panigrahy, ...
Journal of Clinical Oncology 32 (19), 2050-2058, 2014
2142014
Novel and shared neoantigen derived from histone 3 variant H3. 3K27M mutation for glioma T cell therapy
ZS Chheda, G Kohanbash, K Okada, N Jahan, J Sidney, M Pecoraro, ...
Journal of Experimental Medicine 215 (1), 141-157, 2018
2112018
GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α
G Kohanbash, K McKaveney, M Sakaki, R Ueda, AH Mintz, N Amankulor, ...
Cancer research 73 (21), 6413-6423, 2013
2102013
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1
R Ueda, G Kohanbash, K Sasaki, M Fujita, X Zhu, ER Kastenhuber, ...
Proceedings of the National Academy of Sciences 106 (26), 10746-10751, 2009
2052009
Immunotherapeutic approaches for glioma
H Okada, G Kohanbash, X Zhu, ER Kastenhuber, A Hoji, R Ueda, M Fujita
Critical Reviews™ in Immunology 29 (1), 2009
2022009
Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy
X Zhu, M Fujita, LA Snyder, H Okada
Journal of neuro-oncology 104, 83-92, 2011
2012011
Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly …
T Tatsumi, J Huang, WE Gooding, A Gambotto, PD Robbins, ...
Cancer research 63 (19), 6378-6386, 2003
1862003
Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell–based therapeutics
JG Zhang, J Eguchi, CA Kruse, GG Gomez, H Fakhrai, S Schroter, W Ma, ...
Clinical Cancer Research 13 (2), 566-575, 2007
1822007
系统目前无法执行此操作,请稍后再试。
文章 1–20